Drug-labels.com

Riva-Irbesartan (Laboratoire Riva, PM 00076903): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
75 mg, 150 mg, 300 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Riva-Irbesartan (Laboratoire Riva, PM 00076903)

What is RIVA-IRBESARTAN used for?

  • RIVA-IRBESARTAN is used in adults to lower high blood pressure. It can be used alone or together with a thiazide diuretic (a “water pill”).
  • If you have high blood pressure, type 2 diabetes and kidney disease, RIVA-IRBESARTAN may help to protect kidney function

How does RIVA-IRBESARTAN work?

RIVA-IRBESARTAN is an angiotensin receptor blocker (ARB). It lowers blood pressure. This medicine does not cure your disease. It helps to control it. Therefore, it is important to continue taking RIVA-IRBESARTAN regularly even if you feel fine.

What are the ingredients in RIVA-IRBESARTAN?

Medicinal ingredient: Irbesartan.

Non-medicinal ingredients: Colloidal anhydrous silica, croscarmellose sodium, hypromellose, lactose monohydrate, macrogol, magnesium stearate, microcrystalline cellulose, starch pregelatinised, and titanium dioxide

RIVA-IRBESARTAN comes in the following dosage forms:

Tablets 75 mg, 150 mg and 300 mg.

Do not use RIVA-IRBESARTAN if you:

  • are allergic to Irbesartan or to any non-medicinal ingredient in the formulation.
  • have experienced an allergic reaction (angioedema) with swelling of the hands, feet, or ankles, face, lips, tongue, throat, or sudden difficulty breathing or swallowing, to any ARB. Be sure to tell your healthcare professional that this has happened to you.
  • have diabetes or kidney disease and are already taking:

    • a blood pressure-lowering medicine that contains aliskiren (such as Rasilez®)
    • an angiotensin converting enzyme (ACE) inhibitor. You can recognize ACE inhibitors because their medicinal ingredient ends in ‘PRIL’
  • are pregnant or intend to become pregnant. Taking RIVA-IRBESARTAN during pregnancy can cause injury and even death to your baby.

  • are breastfeeding. It is possible that RIVA-IRBESARTAN passes into breast milk.
  • have one of the following rare hereditary diseases:

    • Galactose intolerance
    • Lapp lactase deficiency
    • Glucose-galactose malabsorption

Because lactose is a non-medicinal ingredient in RIVA-IRBESARTAN.

RIVA-IRBESARTAN is not for use in children and adolescents (under the age of 18 years).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take RIVA-IRBESARTAN. Talk about any health conditions or problems you may have, including if you:

  • have experienced an allergic reaction to any drug used to lower blood pressure, including angiotensin converting enzyme (ACE) inhibitors.
  • have narrowing of an artery or a heart valve.
  • have had a heart attack or stroke.
  • have heart failure.
  • have liver or kidney disease.
  • have diabetes. RIVA-IRBESARTAN may cause low blood sugar levels.
  • have psoriasis or a history of psoriasis
  • are on dialysis.
  • are dehydrated or suffer from excessive vomiting, diarrhea, or sweating.
  • are taking a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill” that makes your body keep potassium).
  • are on a low-salt diet.
  • are taking a medicine that contains aliskiren, such as RASILEZ®, used to lower high blood pressure. The combination with RIVA-IRBESARTAN is not recommended.
  • are taking an angiotensin converting enzyme (ACE) inhibitor. The combination with RIVA-IRBESARTAN is not recommended.
  • are taking a medicine that contains lithium. The combination with RIVA-IRBESARTAN is not recommended.

Other warnings you should know about:

Before surgery and general anesthesia (even at the dentist’s office), tell the doctor or dentist that you are taking RIVA-IRBESARTAN, as there may be a sudden fall in blood pressure associated with general anesthesia.

Allergic Reactions: Allergic reactions (swelling of areas of tissue under the skin, sometimes affecting the face and throat, hives and severe allergic reactions) have been reported. Stop taking RIVA-IRBESARTAN and get immediate medical help if you experience any symptoms of an allergic reaction.

Driving and using machines: Before you perform tasks which may require special attention, wait until you know how you respond to RIVA-IRBESARTAN. Dizziness, lightheadedness, or fainting can especially occur after the first dose and when the dose is increased.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with RIVA-IRBESARTAN:

  • Agents increasing serum potassium, such as a salt substitute that contains potassium, potassium supplements, or a potassium-sparing diuretic (a specific kind of “water pill”).
  • Lithium used to treat bipolar disease.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs), used to reduce pain and swelling. Examples include ibuprofen, naproxen, and celecoxib.
  • Blood pressure-lowering drugs, including diuretics (“water pills”), aliskiren-containing products (e.g. RASILEZ®), or angiotensin converting enzyme (ACE) inhibitors.
  • Certain medications tend to increase your blood pressure, for example, preparations for appetite control, asthma, colds, coughs, hay fever and sinus problems.
  • Medicines used to lower blood sugar levels, including insulin and oral medicines, such as repaglinide.

How to take RIVA-IRBESARTAN:

  • Take RIVA-IRBESARTAN tablets every day exactly as prescribed.
  • It is recommended to take your dose at about the same time every day.
  • RIVA-IRBESARTAN may be taken with or without food.

Usual Adult Dose:

Recommended Initial Dose: 150 mg once a day.

Your healthcare professional can increase the dosage to 300 mg once daily if required.

Overdose:

If you think you, or a person you are caring for, have taken too much RIVA-IRBESARTAN, contact a healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you have forgotten to take your dose during the day, carry on with the next dose at the usual time. Do not double the dose.

What are possible side effects from using RIVA-IRBESARTAN?

These are not all the possible side effects you may have when taking RIVA-IRBESARTAN. If you experience any side effects not listed here, tell your healthcare professional.

Side effects may include:

  • dizziness
  • drowsiness, insomnia, being tired
  • rash
  • diarrhea, vomiting
  • headache
  • back or leg pain, muscle cramps
  • lightheadedness
  • ringing in the ears.

RIVA-IRBESARTAN can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Increased levels of potassium in the blood: irregular heartbeats, muscle weakness and generally feeling unwell✓
Increased levels of creatine phosphokinase : blood tests may show raised levels of an enzyme that measures breakdown of muscle (creatine phosphokinase)✓
UNCOMMON
Low blood pressure: dizziness, fainting, light-headedness. May occur when you go from lying or sitting to standing up.✓
Edema: swelling of hands, ankles, or feet✓
Tachycardia: fast heart beat✓
Liver problems: yellowing of the skin or eyes, dark urine, abdominal pain, nausea, vomiting, loss of appetite✓
Kidney problems: change in frequency of urination, nausea, vomiting, swelling of extremities, fatigue✓
RARE
Rhabdomyolysis: muscle pain that you cannot explain, muscle tenderness or weakness, dark brown urine.✓
Allergic reaction and angioedema: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing✓
VERY RARE
Decreased platelets: bruising, bleeding, fatigue and weakness, small purple or red dots under the skin✓
UNKNOWN
Skin problems: psoriasis, increased skin sensitivity to sunlight✓
Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Low blood sugar: sweating, weakness, hunger, dizziness, trembling, headache✓
Anemia (decreased number of red blood cells): fatigue, loss of energy, looking pale, weakness, shortness of breath✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store RIVA-IRBESARTAN tablets at room temperature (15°C to 30°C).

Keep out of reach and sight of children.

If you want more information about RIVA-IRBESARTAN:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/healthcanada/services/drugs-health-products/drug-products/drug-product-database.html); or by calling, Laboratoire Riva Inc., at 1-800-363-7988.

Laboratoire Riva Inc.

660 Boul. Industriel

Blainville, Quebec

J7C 3V4

www.labriva.com

Last Revised: September 03, 2024

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02524732

Revision date stated in the text: September 3, 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Riva-Irbesartan (Laboratoire Riva, PM 00076903)

Rx or OTC
Prescription (Rx)?
DIN 02524732, 02524740, 02524759
Schedule(s) PRESCRIPTION
Active ingredient(s) Irbesartan
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA04 Irbesartan
Company LABORATOIRE RIVA INC.
Current status Marketed
Current status date June 8, 2023
Strengths and forms
DIN Strength Dosage form(s) Current status
02524732 75 MG Tablet Marketed June 8, 2023
02524740 150 MG Tablet Marketed June 8, 2023
02524759 300 MG Tablet Marketed June 8, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.